In breast cancer, Gobert et al. found that Treg within lymphoid infiltrates surrounding the tumor are selectively recruited through CCL22/CCR4 and activated with high levels of membrane GITR and ICOS expression [18]. This evidence concerns the gene CCL22 and breast carcinoma.